Absci Corporation Common Stock

ABSINASDAQ • USD
ThemeAI & Machine Learning›AI Platforms & Infrastructure
6.40 USD
↘ 0.94 (12.81%)AT CLOSE (11:59 AM EDT)
6.46
↗ 0.06 (0.88%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
6.46
↗ 0.06 (0.88%)
🔴Market: CLOSED
Open?$7.10
High?$7.11
Low?$6.22
Prev. Close?$7.34
Volume?5.2M
Avg. Volume?5.3M
VWAP?$6.56
Rel. Volume?0.98x
Bid / Ask
Bid?$6.45 × 4.6K
Ask?$6.50 × 1.4K
Spread?$0.05
Midpoint?$6.48
Valuation & Ratios
Market Cap?997.8M
Shares Out?155.9M
Float?108.6M
Float %?72.2%
P/E Ratio?N/A
P/B Ratio?5.80
EPS?-$0.76
Dividend?0.00%
Ex-Dividend?N/A

ABSI is currently priced at $6.40. There is a divergence between signals — technical indicators rate "Strong Buy" but underlying fundamentals lean "Sell". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 2/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation front, ABSI trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
Themes
AI & Machine Learning›AI Platforms & InfrastructureBiotech - Drug Development›Clinical-Stage Platforms
Employees
140
Market Cap
997.8M
Industry
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Website
www.absci.com
Listed
2021-07-22
Address
18105 SE MILL PLAIN BLVD
VANCOUVER, WA 98683
Phone: (360) 949-1041
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
100
Momentum?
10
Short Sent.?
16
Piotroski F-Score?2/9Weak
Altman Z-Score?32.96Safe
Confidence?51%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?29.68%Squeeze Risk
Short Interest?32.2M
Days to Cover?6.1
Free Float108.6M
Avg Daily Volume5.3M
Settlement Date2026-05-15
Financial Health
Current Ratio?6.59Strong
Quick Ratio?6.59Strong
Cash Ratio?0.43Low
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A▾
P/B?
Peers
100
S&P
32
5.80FAIR▾
P/S?
Peers
100
S&P
3
543.46HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-8.8CHEAP▾
EV/Sales?
Peers
100
S&P
3
538.99HIGH▾
Returns & Efficiency
ROE?
S&P
3
-68.9%WEAK▾
ROA?
S&P
3
-60.6%WEAK▾
Cash Flow & Enterprise
FCF?$-98505000
Enterprise Value?$989.6M
Fundamentals ratios updated end of day
MarketsMoversWatchlist